|
Index of reports
> Cases resulting in death (14)
Below is the selection of adverse event reports related to Indocin (Indomethacin) that includes cases resulting in death.
Adverse event in receiving Indocin (Indomethacin)
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2007-10-17
Patient:
Adverse reactions / side effects: Hyperkalaemia
Adverse event resulted in: death
Suspect drug(s):
Indocin (Indomethacin)
Adverse event in receiving Indocin (Indomethacin)
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2007-10-17
Patient:
Adverse reactions / side effects: Hyperkalaemia, Death Neonatal
Adverse event resulted in: death
Suspect drug(s):
Indocin (Indomethacin)
Adverse event in receiving Indocin (Indomethacin)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-05-10
Patient:
Adverse reactions / side effects: Drug Interaction
Adverse event resulted in: death
Suspect drug(s):
Indocin
Polyethylene Glycol
Adverse event in male receiving Indocin (Indomethacin)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-05-01
Patient: male
Adverse reactions / side effects: Hyperkalaemia, Disseminated Intravascular Coagulation, Neonatal Disorder, Cerebral Haemorrhage Neonatal, Neonatal Infection, Electrocardiogram QRS Complex Prolonged, Patent Ductus Arteriosus, Arrhythmia Neonatal, Neonatal Cardiac Failure, Bradycardia Neonatal, Staphylococcal Infection, NO Therapeutic Response, Platelet Count Decreased, Necrotising Fasciitis, Blood Pressure Decreased, Neutrophil Count Decreased, Shock
Adverse event resulted in: death
Suspect drug(s):
Indocin
Dosage: 0.06 mg; tid; iv
Indication: Patent Ductus Arteriosus
Start date: 2006-06-10
End date: 2006-06-11
Solu-Cortef
Dosage: 2 mg; qd; iv
Indication: Shock
Start date: 2006-06-02
End date: 2006-06-02
Solu-Cortef
Dosage: 2 mg; qd; iv
Indication: Shock
Start date: 2006-06-13
End date: 2006-06-13
Pitressin
Dosage: 1.92 u; qd; iv
Indication: Shock
Start date: 2006-06-08
End date: 2006-06-14
Other drugs received by patient: Ampiclox
Adverse event in receiving Indocin (Indomethacin)
Reported by a physician from Japan on 2007-04-09
Patient: , weighing 1.0 kg (2.2 pounds)
Adverse reactions / side effects: Hyperkalaemia, Disseminated Intravascular Coagulation, Haemorrhage Intracranial, Methicillin-Resistant Staphylococcal Aureus Test Positive, Electrocardiogram QRS Complex Prolonged, Sepsis, Bradycardia, Blood Pressure Decreased, Necrotising Fasciitis
Adverse event resulted in: death
Suspect drug(s):
Hydrocortone Injection
Indication: Blood Pressure Decreased
Hydrocortone Injection
Indication: Urine Output Decreased
Indocin
Amikacina
Indication: Sepsis
Adverse event in receiving Indocin (Indomethacin)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-04-05
Patient:
Adverse reactions / side effects: Drug Interaction
Adverse event resulted in: death
Suspect drug(s):
Indocin
Polyethylene Glycol
Adverse event in 13 year old male receiving Indocin (Indomethacin)
Reported by a physician from United States on 2007-04-04
Patient: 13 year old male
Adverse reactions / side effects: Cardiac Failure Chronic, Coagulopathy, Blood Albumin Decreased, Pyrexia, Cardiomegaly, Pulmonary Fibrosis, Chest Pain, Polyarthritis, Juvenile Arthritis, Hepatosplenomegaly
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Indocin
Administration route: Oral
Indication: Rheumatoid Arthritis
Indocin
Administration route: Oral
Myochrysine
Indication: Juvenile Arthritis
Other drugs received by patient: Aspirin
Adverse event in 56 year old male receiving Indocin (Indomethacin)
Reported by a physician from Japan on 2007-03-15
Patient: 56 year old male, weighing 58.0 kg (127.6 pounds)
Adverse reactions / side effects: Cardio-Respiratory Arrest, Tachycardia, Compartment Syndrome, Depressed Level of Consciousness, Acquired Haemophilia, Blood Pressure Decreased, Haematoma
Adverse event resulted in: death
Suspect drug(s):
Indocin
Administration route: Oral
Indication: Pustular Psoriasis
Tigason
Administration route: Oral
Indication: Pustular Psoriasis
Roxithromycin
Administration route: Oral
Indication: Pustular Psoriasis
Tacalcitol
Administration route: Topical
Indication: Pustular Psoriasis
Difluprednate
Administration route: Topical
Indication: Pustular Psoriasis
Betamethasone Butyrate Propionate
Administration route: Topical
Indication: Pustular Psoriasis
[therapy Unspecified]
Administration route: Topical
Indication: Pustular Psoriasis
Furosemide
Administration route: Oral
Indication: Oedema Peripheral
Adverse event in 56 year old male receiving Indocin (Indomethacin)
Reported by a physician from Japan on 2007-03-02
Patient: 56 year old male, weighing 58.0 kg (127.6 pounds)
Adverse reactions / side effects: Renal Tubular Disorder, Tachycardia, Compartment Syndrome, Acquired Haemophilia, Haemorrhoidal Haemorrhage, Activated Partial Thromboplastin Time Prolonged, Cardio-Respiratory Arrest, Depressed Level of Consciousness, Myoglobin Blood Increased, Coagulation Time Prolonged, Blood Pressure Decreased, Haematoma
Adverse event resulted in: death
Suspect drug(s):
Indocin
Administration route: Oral
Indication: Pustular Psoriasis
Tigason
Administration route: Oral
Indication: Pustular Psoriasis
Roxithromycin
Administration route: Oral
Indication: Pustular Psoriasis
Tacalcitol
Administration route: Topical
Indication: Pustular Psoriasis
Difluprednate
Administration route: Topical
Indication: Pustular Psoriasis
Betamethasone
Administration route: Topical
Indication: Pustular Psoriasis
[therapy Unspecified]
Administration route: Topical
Indication: Pustular Psoriasis
Furosemide
Administration route: Oral
Indication: Oedema Peripheral
Adverse event in 56 year old male receiving Indocin (Indomethacin)
Reported by a physician from Japan on 2007-02-22
Patient: 56 year old male, weighing 58.0 kg (127.6 pounds)
Adverse reactions / side effects: Cardio-Respiratory Arrest, Tachycardia, Compartment Syndrome, Depressed Level of Consciousness, Acquired Haemophilia, Blood Pressure Decreased, Haematoma
Adverse event resulted in: death
Suspect drug(s):
Indocin
Administration route: Oral
Indication: Pustular Psoriasis
Tigason
Administration route: Oral
Indication: Pustular Psoriasis
Roxithromycin
Administration route: Oral
Indication: Pustular Psoriasis
Tacalcitol
Administration route: Topical
Indication: Pustular Psoriasis
Difluprednate
Administration route: Topical
Indication: Pustular Psoriasis
Betamethasone Butyrate Propionate
Administration route: Topical
Indication: Pustular Psoriasis
[therapy Unspecified]
Administration route: Topical
Indication: Pustular Psoriasis
Furosemide
Administration route: Oral
Indication: Oedema Peripheral
Adverse event in female receiving Indocin (Indomethacin)
Reported by a physician from Japan on 2007-01-29
Patient: female, weighing 1.0 kg (2.2 pounds)
Adverse reactions / side effects: Gastric Perforation, Premature Baby, Sepsis, Shock
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Indocin
Indication: Polyhydramnios
Start date: 1991-05-19
End date: 1991-05-20
Indocin
Indication: Tocolysis
Start date: 1991-05-19
End date: 1991-05-20
Adverse event in female receiving Indocin (Indomethacin)
Reported by a physician from Japan on 2007-01-26
Patient: female, weighing 1.0 kg (2.2 pounds)
Adverse reactions / side effects: Ileal Perforation, Premature Baby, Sepsis, Hydrocephalus
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Indocin
Indication: Premature Labour
Start date: 1992-02-03
End date: 1992-02-05
Indocin
Indication: Uterine Hypertonus
Start date: 1992-02-03
End date: 1992-02-05
Adverse event in male receiving Indocin (Indomethacin)
Reported by a physician from Japan on 2007-01-26
Patient: male, weighing 1.0 kg (2.2 pounds)
Adverse reactions / side effects: Gastrointestinal Perforation, Metabolic Acidosis, Neonatal Respiratory Distress Syndrome, Hyperkalaemia, Premature Baby, Tachycardia, Haemorrhage Intracranial, Neonatal Asphyxia, Patent Ductus Arteriosus
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Indocin (Indomethacin)
Adverse event in female receiving Indocin (Indomethacin)
Reported by a physician from Japan on 2007-01-26
Patient: female, weighing 1.0 kg (2.2 pounds)
Adverse reactions / side effects: Apgar Score LOW, Ileal Perforation, Neonatal Respiratory Distress Syndrome, Drug Exposure During Pregnancy, Premature Baby, Patent Ductus Arteriosus
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Indocin
Indication: Uterine Hypertonus
Diclofenac Sodium
Indication: Pyrexia
|
